Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Kalorama Reports | Outsourcing in Drug Discovery, 3rd Edition

Outsourcing in Drug Discovery, 3rd Edition

2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons. New technologies increase the number of targets and accelerate the identification of active compounds. There is increasing pressure to develop new lead compounds due to the near-term loss of patent protection for many drug product. And there is also pressure to reduce the time spent in drug discovery and to bring drugs to market sooner, as well as the ever-present cost considerations.

Kalorama Information's Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market are presented. The trend toward the increased use of offshore suppliers is covered in detail. The report also provides profiles of 23 suppliers, representative of those active in this market.

Segments covered in this report include:

Chemistry Services

Building Blocks

Compound Synthesis

Libraries

Process Research

Other Services

Biology Services

Protein Expression

Structural Analysis

Target Validation

Pathways Analysis

Other Services

Screening Services

Assay Development

Primary Screening

Secondary Screening

Lead Optimization

Early ADMET

Analogues Creation

Computational Support

Other services

In addition to market data and forecasts, the report covers issues such as:

What factors should a client consider when deciding whether to do a project in-house or outsource it?

Is it in the client's best interest to seek a domestic outsourcing partner, or go with an overseas supplier?

How does the client select the CRO that is best for him?

What are the best practices when working with a CRO?

How do you measure his effectiveness?

How do you avoid problems with your CRO?

How do you maximize benefits?

This report looks offshore at outsourcing suppliers based in three major areas: India, China, and Eastern Europe. The relative advantages each country provides are contrasted with some of their limitations. The report asses which projects are moving to which suppliers and why.

May 1, 2008 250 Pages
Table of Contents

Price

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions